Evidence map›Paper›PMID 40587774›Full record

ArticleAnalytical chemistry2025

Cross-Signal Contribution as a Challenge in LC-MS/MS Bioanalysis.

Anna Siemiątkowska, Katarzyna Kosicka-Noworzyń, Marta Karaźniewicz-Łada, Celine Park, Pavel Gershkovich, Leonid Kagan

Abstract read
In one paragraph

Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anna SiemiątkowskaDepartment of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.ORCID 0000-0003-3568-4716
Katarzyna Kosicka-NoworzyńDepartment of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.
Marta Karaźniewicz-ŁadaDepartment of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.
Celine ParkDepartment of Pharmaceutics & Center of Excellence for Pharmaceutical Translational Research and Education, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, New Jersey 08854, United States.
Pavel GershkovichSchool of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, U.K..ORCID 0000-0003-3136-0933
Leonid KaganDepartment of Pharmaceutics & Center of Excellence for Pharmaceutical Translational Research and Education, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, New Jersey 08854, United States.

Funding

Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and AdultsR01AI137080 · NIAID · UNIVERSITY OF VIRGINIA · PI Scott K Heysell, Leonid Kagan · 2018 to 2026
$6.3M
Mechanisms of obesity-induced changes in drug pharmacokineticsR01GM124046 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI KAGAN, LEONID · 2018 to 2022
$2.6M
NIAID NIH HHS R01 AI137080NIGMS NIH HHS R01 GM124046
6 · The paper itself

Abstract

Liquid chromatography-tandem mass spectrometry is one of the most sensitive and reliable techniques in the quantitative bioanalysis of small molecules, but it is not free of challenges and traps. This Tutorial focuses on the possible causes of cross-signal contribution, which is often neglected, with seven real-world case studies in which interferences of different origins were identified and related problems were solved. A flowchart is suggested that guides readers step-by-step to narrow down the plausible reasons for the unexpected peaks in their LC-MS/MS assays. The impact of cross-signal contribution on quantitative bioanalysis is also discussed, along with measures that can be undertaken when the phenomenon has been identified.

Indexed as

Tandem Mass SpectrometryChromatography, LiquidHumansLiquid Chromatography-Mass Spectrometry

Identifiers

PMID40587774
PMCPMC12268833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.